HRMY: financial statements from SEC

Income statement

Metric	31/12/2025	31/12/2024
Revenue	868M	715M
Cost of revenue	198M	157M
Gross profit	670M	558M
Research and development	190M	146M
Selling, general and administrative	153M	110M
Operating expenses	462M	367M
Operating income	208M	191M
Pre-tax income	215M	192M
Income tax	56M	46M
Net income	159M	145M
Earnings per share	2.76	2.56
Earnings per share, diluted	2.71	2.51
Weighted average shares	57M	57M
Weighted average shares, diluted	59M	58M

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	589M	753M	647M	546M	489M	453M	388M	318M
Short-term investments	52M	23M	26M	19M	18M	14M	23M	30M
Receivables	108M	97M	101M	93M	106M	83M	82M	83M
Inventory	5M	5M	7M	6M	6M	7M	7M	6M
Current assets	779M	907M	839M	691M	643M	579M	522M	458M
Property, plant and equipment	—	—	1M	1M	1M	1M	750,000	754,000
Total assets	1.27B	1.27B	1.21B	1.11B	1.06B	999M	928M	858M
Current liabilities	217M	252M	223M	180M	175M	175M	161M	147M
Short-term debt	20M	20M	20M	19M	18M	16M	15M	15M
Long-term debt	139M	144M	149M	153M	158M	163M	168M	171M
Total liabilities	361M	401M	373M	335M	335M	340M	331M	320M
Equity	910M	870M	835M	773M	721M	659M	597M	539M
Shares outstanding	58M	58M	58M	58M	57M	57M	57M	57M
Shares issued	58M	58M	58M	58M	57M	57M	57M	57M

Metric	31/12/2025	31/12/2024
Operating cash flow	348M	220M
Depreciation and amortisation	—	267,000
Share-based compensation	45M	43M
Capital expenditure	310,000	1M
Investing cash flow	−40M	−67M
Financing cash flow	−9M	−11M